Acute Myeloid Leukemia (AML) Latest Advances

Novel Basophilic Crystals in Acute Myeloid Leukemia with EZH2/DNMT3A Mutations: Aggressive Case with Thrombosis.

Journal: Clinical laboratory

Published: April 14, 2026

A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 14, 2026

Targeting FLT-3 Mutations in Acute Myeloid Leukaemia: from Molecular Insights to Clinical Strategies.

Journal: Folia biologica

Published: April 14, 2026

To the Maximal Nuclear Diameter and Cell Cycle Phase of Lymphoblasts or Myeloblasts in Patients Suffering from Acute Lymphoblastic and Myeloblastic Leukaemia. A Simple Morphological and Technical Note.

Journal: Folia biologica

Published: April 14, 2026

Acute hemolytic anemia and methemoglobinemia in a pediatric oncology patient with G6PD deficiency: a case report.

Journal: Pharmacogenomics

Published: April 13, 2026

CRISPR-Cas9 knockout screens to identify drug resistance genes in acute myeloid leukemia.

Journal: Methods in cell biology

Published: April 11, 2026

VE-cadherin NOT-gated CD93 CAR T cells discriminate between AML and healthy endothelial cells.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Aberrant B-Cell Marker Expression in RUNX1::RUNX1T1-Positive Acute Myeloid Leukemia.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: April 10, 2026

5-Azacytidine incorporation into mRNAs disrupts translation and induces ribosome collisions.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in KMT2A r and NPM1 -m AML.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Journal: Leukemia & lymphoma

Published: April 09, 2026

Structure-guided design of 7-azaindole DNMT1 inhibitors active against hypomethylating agent-resistant acute myeloid leukemia.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 09, 2026

Acute Myeloid Leukemia (AML) Latest Advances

Find the Latest Research About Acute Myeloid Leukemia (AML)

Novel Basophilic Crystals in Acute Myeloid Leukemia with EZH2/DNMT3A Mutations: Aggressive Case with Thrombosis.

Novel Basophilic Crystals in Acute Myeloid Leukemia with EZH2/DNMT3A Mutations: Aggressive Case with Thrombosis.

A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation.

A plasma-based DNA test for quantification of disease burden in acute myeloid leukemia patients undergoing bone marrow transplantation.

Targeting FLT-3 Mutations in Acute Myeloid Leukaemia: from Molecular Insights to Clinical Strategies.

Targeting FLT-3 Mutations in Acute Myeloid Leukaemia: from Molecular Insights to Clinical Strategies.

To the Maximal Nuclear Diameter and Cell Cycle Phase of Lymphoblasts or Myeloblasts in Patients Suffering from Acute Lymphoblastic and Myeloblastic Leukaemia. A Simple Morphological and Technical Note.

To the Maximal Nuclear Diameter and Cell Cycle Phase of Lymphoblasts or Myeloblasts in Patients Suffering from Acute Lymphoblastic and Myeloblastic Leukaemia. A Simple Morphological and Technical Note.

Acute hemolytic anemia and methemoglobinemia in a pediatric oncology patient with G6PD deficiency: a case report.

Acute hemolytic anemia and methemoglobinemia in a pediatric oncology patient with G6PD deficiency: a case report.

CRISPR-Cas9 knockout screens to identify drug resistance genes in acute myeloid leukemia.

CRISPR-Cas9 knockout screens to identify drug resistance genes in acute myeloid leukemia.

VE-cadherin NOT-gated CD93 CAR T cells discriminate between AML and healthy endothelial cells.

VE-cadherin NOT-gated CD93 CAR T cells discriminate between AML and healthy endothelial cells.

Aberrant B-Cell Marker Expression in RUNX1::RUNX1T1-Positive Acute Myeloid Leukemia.

Aberrant B-Cell Marker Expression in RUNX1::RUNX1T1-Positive Acute Myeloid Leukemia.

5-Azacytidine incorporation into mRNAs disrupts translation and induces ribosome collisions.

5-Azacytidine incorporation into mRNAs disrupts translation and induces ribosome collisions.

Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in KMT2A r and NPM1 -m AML.

Combined Menin and XPO1 inhibition drive synergistic antileukemic activity in KMT2A r and NPM1 -m AML.

Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Structure-guided design of 7-azaindole DNMT1 inhibitors active against hypomethylating agent-resistant acute myeloid leukemia.

Structure-guided design of 7-azaindole DNMT1 inhibitors active against hypomethylating agent-resistant acute myeloid leukemia.